Clinical Trial Update: Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating multiple oral doses of PPM-204 in healthy Japanese male subjects has completed; sponsor Wyeth (now part of Pfizer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• PPM-204

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED